Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Celebrating 100 Episodes: Top MSL Insights, Career Tips, and Community Gratitude
Summary
In the milestone 100th episode of MSL Talk, Tom Caravela celebrates the journey of the podcast and extends gratitude to the supportive community. Reflecting on the podcast's evolution, Tom quizzes listeners on the most downloaded episode and revisits highlights and essential MSL attributes from the early days. He delves into topics like emotional intelligence, career transitions, and field medical excellence. The episode covers crucial aspects of career progression, market saturation, and effective job search strategies. Tom emphasizes the significance of diversity, networking, and personal growth, concluding with a heartfelt expression of gratitude and a recap of key insights.
Please join me for a very special MSL Talk Podcast milestone.
This episode marks our 100th since we started back on March 27th, 2020.
In this episode, I will offer some fun facts, statistics, and behind-the-scenes information, as well as provide a recap per category.
Special thanks to ALL of my awesome guests over the past 2 years and of course, thank YOU to our listeners throughout the world.
MSL Podcast, Medical Science Liaison, Career Progression, Emotional Intelligence, Networking Strategies
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary